Cargando…
Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis
(1) Background: Circulating tumor DNA (ctDNA) has emerged as a promising biomarker for many kinds of tumors. However, whether ctDNA could be an accurate diagnostic biomarker in colorectal cancer (CRC) remains to be clarified. The aim of this study was to evaluate the diagnostic accuracy of ctDNA in...
Autores principales: | Min, Liang, Chen, Jinghua, Yu, Meihong, Liu, Deliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860998/ https://www.ncbi.nlm.nih.gov/pubmed/36675337 http://dx.doi.org/10.3390/jcm12020408 |
Ejemplares similares
-
Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta‐analysis
por: Zhang, Ziying, et al.
Publicado: (2019) -
Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer
por: Osumi, Hiroki, et al.
Publicado: (2020) -
Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017) -
Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016) -
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)